Xintela (XINT.ST) Stock Price

Xintela Price

OMX·CLOSED
0.16
​
Market closed

Over the last 11 years Xintela grew revenue by 63.8% annually, reaching 2.28 M SEK. For Xintela, the net margin of -2,128.1% is down versus -1,613.9% a few years ago.

Xintela stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xintela business model & stock analysis

Xintela AB, based in Lund, Skåne, develops pharmaceutical products in the Health Care sector, specifically focusing on regenerative medicine for cartilage damage and osteoarthritis, as well as treatments for glioblastoma brain tumors. The company utilizes therapeutic antibodies and XINMARK, a marker technology using specific proteins to identify stem cells for cartilage development. Listed on 22 March 2016, Xintela operates within biotechnology, targeting innovative therapies in oncology and orthopedics.

Frequently asked questions about Xintela

Converted at the current exchange rate, the Xintela share trades at 0.01 EUR (0.16 SEK).

The Xintela share (XINT.ST) is listed on 3 stock exchanges, including: Frankfurt (1XT.F), Stockholm (XINT.ST).

The expected revenue of Xintela is 12.45 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Xintela is -17.23 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Xintela is currently -7.87. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Xintela stock.

The price-to-sales ratio (P/S) of Xintela is currently 10.89. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Xintela stock.

The Eulerpool Quality Score for Xintela is 4/10.

The ISIN of Xintela is SE0007756903. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Xintela is A2AF7J. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Xintela is XINT.ST. The ticker symbol is used to trade Xintela shares on the stock exchange.

Fair ValueTerminal
0.13 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website xintela.se
Country
Sweden
Currency
SEK
Initial public offering
Mar 22, 2016
ISIN
SE0007756903
Cusip
W989B4108
Market capitalization
139.96 M SEKMicro Cap
52-Week Range
PEG
-0.33
P/E ratio
P/Ee 2026
-7.87
P/Ee 2027
-0.98
P/Ee 2028
-2.25
P/Ee 2029
-3.94
P/Ee 2030
-5.25
P/Se
10.89
EV/EBIT
—
P/B Ratio
31.95
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-329.76 %
Last updated Oct 16, 2026, 5:19 PM

Xintela Peer Group

Xintela Ticker

FRANKFURT · 1XT.FSTOCKHOLM · XINT.STSTOCKHOLM · XINT.ST

Xintela FIGI

XINT:SF · BBG00CGSPCY31XT:GR · BBG00DJ2B6B81XT:GF · BBG00DJ2B6C71XT:GB · BBG00DJ2B6J0XINTS:PO · BBG00JL6ZNM8XINTSEK:X2 · BBG00JL737W5XINTSEK:XB · BBG00JL737X4XINTSEK:XH · BBG00JL737Z2XINTSEK:XF · BBG00JL73817XINTSEK:XE · BBG00JL73835XINTSEK:XJ · BBG00JL73844XINTSEK:XL · BBG00JL73853